2024-12-19 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Review

**1. Performance Comparison & Divergence:**

Colgate-Palmolive Co (CL) is a consumer goods company producing and marketing household and personal care products.  The cumulative return of CL is 42.08%, significantly lagging behind the S&P 500 (VOO) which has a cumulative return of 114.36%.  The divergence is -72.3%, placing it at the 8.7th percentile of its historical range of divergence against the S&P 500. This indicates CL's underperformance relative to the broader market over the analyzed period.  The provided CAGR data shows inconsistent performance, with periods of strong growth and significant declines. The Alpha consistently around 0.2 indicates a slightly positive excess return compared to the market, but the Beta suggests a relatively high sensitivity to market movements.


**2. Recent Price Movement:**

* **Closing Price:** $92.75
* **5-day Moving Average:** $93.23
* **20-day Moving Average:** $94.50
* **60-day Moving Average:** $96.30

The current price is below all three moving averages, suggesting a downward trend in the short to medium term.


**3. Technical Indicators and Expected Return:**

* **RSI:** 31.07 (Suggests the stock is in oversold territory)
* **PPO:** -0.11 (Indicates bearish momentum)
* **Relative Strength Change (20-day):** +8.7 (Short-term upward momentum, but needs further confirmation)
* **Expected Return:** 0.0% (This is a stated value; further analysis and market context are needed for a more realistic estimate).  The current price of $92.75 doesn't show a significant spike to suggest a sudden jump or drop.  However, the combination of low RSI and negative PPO signals a potential continued downside.  Long-term (2+ years) investment with regular contributions might mitigate the risk of short-term market fluctuations. The relatively low expected return, compared to the S&P 500, needs to be considered against the potential for dividends and the overall risk tolerance.


**4. Recent Earnings Analysis:**

The latest quarterly results show a slight decline in both revenue and EPS compared to the previous quarter (Q2 2024). While revenue remains relatively stable around $5 Billion, EPS has decreased from $0.89 to $0.86 and then to $0.9. There's no information provided to compare these results against analyst expectations. The overall trend in revenue shows some stability, while EPS shows a slight downward movement during the period, however this is a very short time frame and may not represent a long term trend.


**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue has shown minor fluctuations within a relatively narrow range in the past few quarters. Profit margins are consistently high but have slightly declined in recent quarters, possibly reflecting increased operating costs or reduced pricing power.
* **Capital and Profitability:**  ROE figures are highly volatile and potentially unreliable. Extreme variations (e.g., -7866.67%) suggest potential issues with the equity calculation or the accounting methodology used. Further investigation into the composition of equity is necessary to provide a meaningful interpretation.


**6. News and Recent Issues:**

No specific news or recent market outlook is provided, along with analyst opinions and performance highlights. This information is crucial for a complete analysis.


**7. Overall Analysis:**

Colgate-Palmolive (CL) is currently underperforming the S&P 500, showing a significant negative divergence.  Technical indicators suggest an oversold condition, but this alone is not enough to call a bottom.  Recent earnings show some slowing, but remain stable within a narrow margin, and further research is necessary to understand the equity volatility.  The lack of recent news and analyst opinions significantly limits the scope of this analysis. To make an informed investment decision, more information is required, particularly regarding market outlook, analyst expectations, and a thorough review of the financial statements to explain the high volatility in ROE and the stability of Revenue.  The current situation warrants caution, and further due diligence is strongly recommended before any investment decisions.


**8. Disclaimer:** This analysis is based solely on the limited data provided and should not be considered financial advice.  Conduct thorough research and consult a financial advisor before making any investment decisions.
